1st ICMC International Congress May 4, 2016 in Paris

9:00 – 9:15
Welcome and Introduction, President of the National Academy of Medicine And Ph. Bouchard (F)

9:15 – 9:20:
ICMC: An advocate for Male Contraception, D. Serfaty (F)

Session 1:

Chair: Cristina Meriggiola (I), Ronald Swerdloff (USA)

9:20 -9:50:
Gender equity and needs for male contraception, J. Townsend (USA)
Take home message: pdf

9:50 – 10:20:
Overview of hormonal methods, E. Nieschlag (D)
Take home message: pdf

10:20 -10:40, Break

10:40 – 11:10:
New promising non-hormonal targets, D. Blithe (USA)
Take home message: pdf

11:10 – 11:40
New strategies, targets, and leads for male contraception, N. Simmons (USA)
Take home message: pdf

11:40 – 12:10
WHO Efficacy and Safety study, H. Behre (D)
Take home message: pdf
12:10 – 12:40:
Androgens for male contraception and mood, F.C. Wu (UK)
Take home message: pdf

12:40 – 1:40, Lunch

Session 2:

Chair: Richard Anderson (UK), William Bremner (USA)

1:40 – 2:00
MENT: a tissue-selective Androgen for male contraception, R. Sitruk-Ware, N. Kumar (F/USA)
Take home message: pdf

2:00 -2:30:
NES/T transdermal gels, C. Wang (USA)
Take home message: pdf

2:30 -3:00:
DMAU: an oral male hormonal contraceptive, S. Page (USA)
Take home message: pdf
3:00 – 3:30:
Vasalgel and other surgical options, D. Sokal (USA)
Take home message: pdf

3:30 – 4:00
General Discussion: Future Actions

Questions for the Discussion:

• How to find financial support for further research on male contraception?
• How to involve advocacy groups in promoting the needs for new methods for men?
• What would be needed to get industry back in this research field?

4:00 – 4:15, Wrap up and Conclusions